(Q40405905)

English

Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections

scientific article published on October 2005

Statements

Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections (English)
Jacobsen F
Mittler D
Hirsch T
Gerhards A
Lehnhardt M
Steinau HU
Steinstraesser L
1 October 2005
1494-1502

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit